Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOC: Fingolimod vs Standard DMT in RRMS
NCT01534182Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started Jan 2012; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01534182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534182.